This accelerated service is designed to help academia and industry in molecular discovery in the areas of therapeutics, diagnostics, and probe development.
Catégorie : Communiqué de presse
Funding will focus on the development of antibiofilm therapeutics.
Funds will contribute to studying an array of human diseases.
Prof Gets $2-Million Grant to Study Drug-Resistant Pathogens
The Canadian Glycomics Network (GlycoNet), Canada’s first national research network focused on the study of glycomics, has awarded 17 research grants totaling more than $9.6 million.
David Bundle will be honoured at a symposium July 16 and 17 for his achievements as one of the world’s foremost authorities in carbohydrate chemistry.
GlycoNet Investigators describe the development of an improved enzyme that takes us a step closer to having universal blood.
By Michael Brown (Edmonton – April 10, 2015) The University of Alberta has been awarded four new Canada Research Chairs (CRC) to go along with one advancement, worth a total of $5.2 million. New Tier 1 Chairs, designations that come with a $1.4-million award to be paid out over seven years, include business professor Michael […]
The University of Alberta is about to become a house of carbs.
With the official launch of the Canadian Glycomics Network (GlycoNet) on April 10, Canada is poised for international leadership in the field of carbohydrate chemistry, which offers promising solutions to many unmet human health needs, including potential new treatments for conditions ranging from genetic diseases to influenza.